Zyphar'S Pharmaceutics Profile
Key Indicators
- Authorised Capital ₹ 4.95 Cr
as on 21-12-2024
- Paid Up Capital ₹ 4.95 Cr
as on 21-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.09 Cr
as on 21-12-2024
- Satisfied Charges ₹ 6.50 Cr
as on 21-12-2024
- Revenue -26.67%
(FY 2022)
- Profit -62.14%
(FY 2022)
- Ebitda -41.31%
(FY 2022)
- Net Worth 46.37%
(FY 2022)
- Total Assets 44.10%
(FY 2022)
About Zyphar'S Pharmaceutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.95 Cr and a paid-up capital of Rs 4.95 Cr.
The company currently has active open charges totaling ₹13.09 Cr. The company has closed loans amounting to ₹6.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahendra Jain, Rajeshkumar Jain, Kapil Sonigara, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231PN2006PTC022042
- Company No.
022042
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zyphar's Pharmaceutics Private Limited offer?
Zyphar'S Pharmaceutics Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Antibacterial Drugs, Ertapenem Injection, Antibiotic Injection, Ceftriaxone Injection, Injectable Products, Esomeprazole Drugs, Esomeprazole Tablet, Meropenem Injection.
Who are the key members and board of directors at Zyphar'S Pharmaceutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshkumar Jain  | Managing Director | 17-Feb-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahendra Jain | Director | 17-Feb-2006 | Current |
| Kapil Sonigara | Director | 17-Feb-2006 | Current |
| Roshan Jain | Director | 17-Feb-2006 | Current |
Financial Performance of Zyphar'S Pharmaceutics.
Zyphar'S Pharmaceutics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.67% decrease. The company also saw a substantial fall in profitability, with a 62.14% decrease in profit. The company's net worth Soared by an impressive increase of 46.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zyphar'S Pharmaceutics?
In 2022, Zyphar'S Pharmaceutics had a promoter holding of 57.74% and a public holding of 42.26%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zyphar's Biopharmaceuticals Private LimitedActive 3 years 15 daysRajeshkumar Jain is a mutual person
Sinsan Pharmaceuticals Private LimitedActive 17 years 1 monthMahendra Jain, Rajeshkumar Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jun 2021 | ₹2.32 M | Open |
Others Creation Date: 17 Jun 2021 | ₹1.60 M | Open |
Others Creation Date: 22 Oct 2019 | ₹1.00 Cr | Open |
How Many Employees Work at Zyphar'S Pharmaceutics?
Zyphar'S Pharmaceutics has a workforce of 146 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zyphar'S Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zyphar'S Pharmaceutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
